Making sense of medical marijuana

Proceedings of the Association of American Physicians

Volumn 111, Issue 2, 1999, Pages 159-165

  Rosenthal, M S ^a   Kleber, H D ^a  

^a Columbia University ^*  (United States)

Author keywords

Adolescent substance abuse; FDA review process; Medicinal use of cannabis; Treatment

Indexed keywords

ANALGESIC AGENT; ANTIEMETIC AGENT; APPETITE STIMULANT; CANNABIS; DRONABINOL; SPASMOLYTIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER; CANCER PATIENT; DRUG APPROVAL; DRUG EFFICACY; DRUG INDICATION; FOOD AND DRUG ADMINISTRATION; GLAUCOMA; HUMAN; IMMUNE DEFICIENCY; LUNG DISEASE; MULTIPLE SCLEROSIS; PAIN; PSYCHOLOGICAL ASPECT; REVIEW; RISK BENEFIT ANALYSIS;

EID: 0033021148     PISSN: 1081650X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1381.1999.09251.x     Document Type: Review

References (14)